Who owns DBVT?
Institutional ownership of DBV Technologies S.A. from Form 13F, Q2 2026
78 institutional managers reported holding DBV Technologies S.A. (DBVT) in Form 13F filings for Q2 2026, with 21,527,893 shares worth $353M. The largest reported holder was MPM Bioimpact LLC. Managers that filed both quarters added a net 350,752 shares (+1.7%). 17 opened new positions and 10 sold out.
- Funds holding
- 78
- Value held
- $353M
- New / sold out
- 17 / 10
- Net shares, same filers
- +1.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DBVT
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| MPM Bioimpact LLC | $60.1M | 17.0% | 3,666,284 | Trimmed |
| Siren, L.L.C. | $30.5M | 8.6% | 1,857,362 | Unchanged |
| Vivo Capital, LLC | $30.3M | 8.6% | 1,844,758 | Trimmed |
| Perceptive Advisors LLC | $27.1M | 7.7% | 1,653,350 | Added |
| Baker Bros. Advisors LP | $24.0M | 6.8% | 1,461,425 | Unchanged |
| Artisan Partners Limited Partnership | $22.5M | 6.4% | 1,372,851 | Trimmed |
| UBS Group AG | $21.5M | 6.1% | 1,313,439 | Added |
| Morgan Stanley | $15.7M | 4.4% | 954,908 | Added |
| Logos Global Management LP | $15.0M | 4.3% | 915,000 | New |
| Patient Square Capital LP | $14.9M | 4.2% | 909,474 | Added |
| Octagon Capital Advisors LP | $9.4M | 2.7% | 574,200 | Unchanged |
| ADAR1 Capital Management, LLC | $8.7M | 2.5% | 528,295 | Trimmed |
| Ikarian Capital, LLC | $8.6M | 2.4% | 525,000 | Unchanged |
| Redmile Group, LLC | $6.7M | 1.9% | 410,440 | Trimmed |
| Duquesne Family Office LLC | $6.3M | 1.8% | 383,363 | Unchanged |
| Ameriprise Financial Inc | $6.2M | 1.8% | 378,497 | Added |
| Millennium Management LLC | $4.4M | 1.2% | 267,783 | Trimmed |
| Elmind Capital, LP | $4.3M | 1.2% | 265,000 | Unchanged |
| Jane Street Group, LLC | $3.7M | 1.0% | 223,915 | Added |
| Ishara Investments LP | $3.0M | 0.9% | 184,500 | Added |
| Yiheng Capital Management, L.P. | $2.8M | 0.8% | 170,142 | Unchanged |
| Boothbay Fund Management, LLC | $2.7M | 0.8% | 163,401 | Unchanged |
| Great Point Partners LLC | $2.6M | 0.7% | 156,906 | New |
| HRT Financial LP | $2.5M | 0.7% | 151,197 | Added |
| New York State Common Retirement Fund | $2.0M | 0.6% | 119,335 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 21,527,893 DBVT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- UBS Group AG Added+$20.2M
- Logos Global Management LP New+$15.0M
- Morgan Stanley Added+$13.3M
- Perceptive Advisors LLC Added+$11.3M
- Patient Square Capital LP Added+$3.5M
- Jane Street Group, LLC Added+$3.5M
- Great Point Partners LLC New+$2.6M
- Ameriprise Financial Inc Added+$2.4M
- HRT Financial LP Added+$2.1M
- Ishara Investments LP Added+$1.3M
Biggest sellers in Q2 2026
- MPM Bioimpact LLC Trimmed-$25.4M
- Artisan Partners Limited Partnership Trimmed-$13.9M
- Vivo Capital, LLC Trimmed-$13.5M
- ADAR1 Capital Management, LLC Trimmed-$7.9M
- Atika Capital Management LLC Sold out-$5.7M
- Balyasny Asset Management L.P. Sold out-$4.9M
- Redmile Group, LLC Trimmed-$1.3M
- Millennium Management LLC Trimmed-$839K
- New York State Common Retirement Fund Trimmed-$801K
- Nan Fung Trinity (hk) LTD Sold out-$775K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $80.2M and sold $77.3M; 17 added and 24 trimmed.
Schedule 13D and 13G filings on DBVT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-06RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2026-02-03Artisan Partners Limited Partnership SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2025-12-08JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2025-08-12Adage Capital Management, L.P. SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2025-04-14CITADEL ADVISORS LLC SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2025-04-11SUVRETTA CAPITAL MANAGEMENT, LLC SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
- 2025-04-08Vivo Opportunity Fund Holdings, L.P. SCHEDULE 13G filed by DBV Technologies S.A.Schedule 13G
Questions about DBVT ownership
- Who owns DBVT stock?
- 78 institutional investment managers reported DBVT positions in their Form 13F filings for Q2 2026, holding 21,527,893 shares worth $353M in total. MPM Bioimpact LLC reported the largest position.
- Are funds buying or selling DBVT?
- In Q2 2026, 17 managers opened new DBVT positions, 17 added, 24 trimmed and 10 sold out. Managers that filed in both quarters added a net 350,752 shares.
- How current is this DBVT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DBVT by CUSIP. Options are left out. DBVT news and filings · DBVT insider trades · Top funds